
iiCON launches new platform for long-acting medicines
The Infection Innovation Consortium: iiCON has launched a new agreement with the Centre of Excellence for Long-Acting Therapeutics (CELT) at the University of Liverpool that will enable iiCON partners and collaborators to access the expertise and capability at CELT. CELT is a research centre focused on the… Read More















